Silvia Haffner

657 total citations
12 papers, 530 citations indexed

About

Silvia Haffner is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Silvia Haffner has authored 12 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Silvia Haffner's work include Hematopoietic Stem Cell Transplantation (4 papers), Immune Response and Inflammation (3 papers) and Mesenchymal stem cell research (2 papers). Silvia Haffner is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), Immune Response and Inflammation (3 papers) and Mesenchymal stem cell research (2 papers). Silvia Haffner collaborates with scholars based in Germany, Italy and Ireland. Silvia Haffner's co-authors include Günther Eißner, Ernst Holler, Reinhard Andreesen, Silvia Kirchner, Y Ladilov, H. M. Piper, H Maxeiner, Sonja Bauer, Armin Gerbitz and Massimo Iacobelli and has published in prestigious journals such as Blood, American Journal of Physiology-Heart and Circulatory Physiology and Journal of Leukocyte Biology.

In The Last Decade

Silvia Haffner

12 papers receiving 505 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Silvia Haffner Germany	9	202	173	117	85	82	12	530
Piera Filomena Fiore Italy	16	258 1.3×	172 1.0×	84 0.7×	33 0.4×	52 0.6×	25	660
Varsha Vakil United States	8	151 0.7×	137 0.8×	35 0.3×	46 0.5×	60 0.7×	8	550
Jessica Cuerquis Canada	12	171 0.8×	200 1.2×	49 0.4×	50 0.6×	198 2.4×	17	529
Adipong Brickshawana United States	6	120 0.6×	175 1.0×	42 0.4×	72 0.8×	35 0.4×	7	427
Lisa M. Vincent United States	10	239 1.2×	71 0.4×	111 0.9×	60 0.7×	66 0.8×	19	659
Fumihito Tajima Japan	14	234 1.2×	209 1.2×	287 2.5×	37 0.4×	191 2.3×	29	741
John L. Blount United States	10	249 1.2×	532 3.1×	72 0.6×	41 0.5×	164 2.0×	10	814
Thomas A. Selvaggi United States	5	141 0.7×	164 0.9×	28 0.2×	40 0.5×	203 2.5×	5	523
Tina Rasper Germany	10	232 1.1×	122 0.7×	343 2.9×	178 2.1×	307 3.7×	17	748
Valentina d’Escamard United States	7	228 1.1×	70 0.4×	32 0.3×	132 1.6×	73 0.9×	15	539

Countries citing papers authored by Silvia Haffner

Since Specialization

Citations

This map shows the geographic impact of Silvia Haffner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Haffner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Haffner more than expected).

Fields of papers citing papers by Silvia Haffner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Haffner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Haffner. The network helps show where Silvia Haffner may publish in the future.

Co-authorship network of co-authors of Silvia Haffner

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Haffner. A scholar is included among the top collaborators of Silvia Haffner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Haffner. Silvia Haffner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Cahill, Emer, Silvia Haffner, Ernst Holler, et al.. (2016). Mesenchymal Stromal Cells Protect Endothelial Cells from Cytotoxic T Lymphocyte‐Induced Lysis. Scandinavian Journal of Immunology. 84(3). 158–164. 6 indexed citations

Eißner, Günther, et al.. (2011). CD4+CD25+FoxP3+ regulatory T cells enhance the allogeneic activity of endothelial-specific CD8+/CD28-CTL. International Immunology. 23(8). 485–492. 5 indexed citations

Eissner, Guenther, et al.. (2011). Regulatory T Cells Enhance the Allogeneic Activity of Endothelial-Specific Cytotoxic T Lymphocytes – Protective Effect of Defibrotide. Blood. 118(21). 4693–4693. 1 indexed citations

Haffner, Silvia, et al.. (2010). Umbilical cord tissue-derived mesenchymal stem cells grow best under GMP-compliant culture conditions and maintain their phenotypic and functional properties. Journal of Immunological Methods. 363(1). 80–89. 55 indexed citations

Koehl, Gudrun E., Edward K. Geissler, Massimo Iacobelli, et al.. (2007). Defibrotide: An endothelium protecting and stabilizing drug, has an anti-angiogenic potential in vitro and in vivo. Cancer Biology & Therapy. 6(5). 686–690. 29 indexed citations

Gottfried, Eva, Marina Kreutz, Silvia Haffner, et al.. (2007). Differentiation of Human Tumour‐associated Dendritic Cells into Endothelial‐like Cells: An Alternative Pathway of Tumour Angiogenesis. Scandinavian Journal of Immunology. 65(4). 329–335. 54 indexed citations

Vudattu, Nalini, Ernst Holler, Patricia C. Ewing, et al.. (2005). Reverse signalling of membrane‐integrated tumour necrosis factor differentially regulates alloresponses of CD4⁺ and CD8⁺ T cells against human microvascular endothelial cells. Immunology. 115(4). 536–543. 25 indexed citations

Eißner, Günther, Massimo Iacobelli, Stephan Blüml, et al.. (2005). Oligotide, a defibrotide derivative, protects human microvascular endothelial cells against fludarabine-induced activation, damage and allogenicity. Bone Marrow Transplantation. 35(9). 915–920. 10 indexed citations

Kirchner, Silvia, Ernst Holler, Silvia Haffner, Reinhard Andreesen, & Günther Eißner. (2004). Effect of different tumor necrosis factor (TNF) reactive agents on reverse signaling of membrane integrated TNF in monocytes. Cytokine. 28(2). 67–74. 71 indexed citations

10.

Kirchner, Silvia, Walter Kölch, Silvia Haffner, et al.. (2003). LPS resistance in monocytic cells caused by reverse signaling through transmembrane TNF (mTNF) is mediated by the MAPK/ERK pathway. Journal of Leukocyte Biology. 75(2). 324–331. 55 indexed citations

11.

Eißner, Günther, Gabriele Multhoff, Armin Gerbitz, et al.. (2002). Fludarabine induces apoptosis, activation, and allogenicity in human endothelial and epithelial cells: protective effect of defibrotide. Blood. 100(1). 334–340. 109 indexed citations

12.

Ladilov, Y, et al.. (1999). Cardioprotective effects of KB-R7943: a novel inhibitor of the reverse mode of Na⁺/Ca²⁺exchanger. American Journal of Physiology-Heart and Circulatory Physiology. 276(6). H1868–H1876. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact